The Indian government has approved the emergency use of the new coronavirus drug Molnupiravir, which was also approved in Japan last week.
India's Minister of Health and Family Welfare, Mandavia, posted on Twitter on the 28th that it has approved the new coronavirus drug "molnupiravir" for use in emergencies.
It is planned to be manufactured by 13 domestic companies in the future.
Molnupiravir was developed by Merck, a major American pharmaceutical company, and was started in clinical trials for adults at high risk of aggravation within 5 days of onset, reducing the risk of hospitalization by 30%. Has been announced.
In the United States, the FDA = Food and Drug Administration issued an "emergency use permission" on the 23rd of this month, and on the 24th in Japan, it was officially approved as the first drug to be taken.
In India, on the 28th, two types of vaccines for the new coronavirus manufactured by domestic companies were also newly approved for emergency use.
In India, the second wave since April has caused an explosive spread of infection, with more than 400,000 people infected each day, and there are persistent concerns among the people about the third wave.
For this reason, the government is calling on the people to take a calm response, saying that the medical system, including medicines and vaccines, is being improved.